General MedicationsINJECTIONStandard
IXIFI
INFLIXIMAB-QBTX
Standard Dose
100MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary
Approval overview IXIFI is listed in Drugs@FDA under application 761072 (BLA).
Marketing status: Prescription Active ingredient INFLIXIMAB-QBTX Form and strength INJECTABLE;INJECTION - 100MG/VIAL Sponsor PFIZER INC Submission history Latest submission status date: 2025-10-09 00:00:00.
Structured Monograph
Clinical summary
Approval overview IXIFI is listed in Drugs@FDA under application 761072 (BLA). Marketing status: Prescription Active ingredient INFLIXIMAB-QBTX Form and strength INJECTABLE;INJECTION - 100MG/VIAL Sponsor PFIZER INC Submission history Latest submission status date: 2025-10-09 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
Interaction Notes
- No interaction notes stored yet.